Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2014NeurologyOpen Access

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

View Full Paper
Ask AI
Bookmark
Share

Authors

EMElizabeth C. MorminoNeurosciences InstituteRBRebecca A. BetenskyNew York UniversityTHTrey HeddenIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mormino et al. (2014) studied this question.

synapsesocial.com/papers/6a7c8d9bfecf32cfa0610de4https://doi.org/10.1212/wnl.0000000000000431
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age2009 · 298 citations
  2. 2Gender and age modify the association between APOE and AD-related neuropathology2001 · 108 citations
  3. 3Apolipoprotein E <i>ε4</i> Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy1996 · 258 citations
  4. 4Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011 · 7,297 citations
  5. 5Aβ amyloid, cognition, and APOE genotype in healthy older adults2012 · 59 citations